190 related articles for article (PubMed ID: 27347147)
1. Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia.
Song K; Li M; Xu X; Xuan LI; Huang G; Liu Q
Oncol Lett; 2016 Jul; 12(1):334-342. PubMed ID: 27347147
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α and GLUT1 gene expression is associated with chemoresistance of acute myeloid leukemia.
Song K; Li M; Xu XJ; Xuan L; Huang GN; Song XL; Liu QF
Asian Pac J Cancer Prev; 2014; 15(4):1823-9. PubMed ID: 24641416
[TBL] [Abstract][Full Text] [Related]
4. Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.
Zhe N; Wang J; Chen S; Lin X; Chai Q; Zhang Y; Zhao J; Fang Q
Hematology; 2015 Aug; 20(7):384-91. PubMed ID: 26218201
[TBL] [Abstract][Full Text] [Related]
5. HMGCS1 drives drug-resistance in acute myeloid leukemia through endoplasmic reticulum-UPR-mitochondria axis.
Zhou C; Li J; Du J; Jiang X; Xu X; Liu Y; He Q; Liang H; Fang P; Zhan H; Zeng H
Biomed Pharmacother; 2021 May; 137():111378. PubMed ID: 33601148
[TBL] [Abstract][Full Text] [Related]
6. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY
Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
Lin M; Hu J; Liu T; Li J; Chen B; Chen X
Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
[TBL] [Abstract][Full Text] [Related]
9. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.
Marín-Hernández A; Gallardo-Pérez JC; Ralph SJ; Rodríguez-Enríquez S; Moreno-Sánchez R
Mini Rev Med Chem; 2009 Aug; 9(9):1084-101. PubMed ID: 19689405
[TBL] [Abstract][Full Text] [Related]
10. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells.
Li Y; Guo Y; Feng Z; Bergan R; Li B; Qin Y; Zhao L; Zhang Z; Shi M
Nutr Cancer; 2019; 71(6):1007-1018. PubMed ID: 31032633
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of Apoptosis for Resveratrol-mediated Reversing the Drug-resistance of AML HL-60/ADR cells].
Guo YK; Shi M; Qin YL; Li YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):736-742. PubMed ID: 28641627
[TBL] [Abstract][Full Text] [Related]
14. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.
Li Q; Song W; Wang J
Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433
[TBL] [Abstract][Full Text] [Related]
15. The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia.
Deng L; Jiang L; Lin XH; Tseng KF; Liu Y; Zhang X; Dong RH; Lu ZG; Wang XJ
Acta Pharmacol Sin; 2017 Mar; 38(3):382-391. PubMed ID: 28042875
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Inhibiting
Li LY; Nie ZY; Zhang XY; Luo JM; Yang L; Wang Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1038-1043. PubMed ID: 37551474
[TBL] [Abstract][Full Text] [Related]
17. [Expression of HIF-1α in primary acute myeloid leukemia cells and its relationship with prognosis].
Chen P; Jiang X; Huang HF; Yuan Q; Wu JY; Guo YF; Chen YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):19-23. PubMed ID: 25687039
[TBL] [Abstract][Full Text] [Related]
18. [Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism].
Li BH; Yuan L; Shi RR; Wang JG
Sheng Li Xue Bao; 2015 Dec; 67(6):611-7. PubMed ID: 26701637
[TBL] [Abstract][Full Text] [Related]
19. [Newly Diagnosed Acute Myeloid Leukemia Patients-Derived Bone Marrow Mesenchymal Stem Cells Suppress Daunorubicin Induced HL-60 Cell Apoptosis via Modulating Caspase-3/Survivin].
Ning HM; Wang J; Su YF; Xu C; Hu JW; Lou X; Li XS; Mao N; Chen H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1736-1741. PubMed ID: 31839031
[TBL] [Abstract][Full Text] [Related]
20. Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models.
Portwood S; Lal D; Hsu YC; Vargas R; Johnson MK; Wetzler M; Hart CP; Wang ES
Clin Cancer Res; 2013 Dec; 19(23):6506-19. PubMed ID: 24088735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]